Yahoo Finance Should You Be Holding Capricor Therapeutics Inc (NASDAQ:CAPR)?
Capricor Therapeutics Inc (NASDAQ:CAPR) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the case of CAPR, it is a financially-robust company with a an optimistic growth outlook, not yet factored into the price. In the following section, I expand a bit more on these key aspects. For those interested in understanding where the figures come from and want to see the analysis, take a look at the report on Capricor Therapeutics here.
Very undervalued with flawless balance sheet
CAPR’s shares are now trading at a price below its true value based on its discounted cash flows, indicating a relatively pessimistic market sentiment. This mispricing gives investors the opportunity to buy into the stock at a cheap price compared to the value they will be receiving, should analysts’ consensus forecast growth be correct. Compared to the rest of the biotechs industry, CAPR is also trading below its peers, relative to earnings generated. This further reaffirms that CAPR is potentially undervalued.
CAPR’s ability to maintain an adequate level of cash to meet upcoming liabilities is a good sign for its financial health. This indicates that CAPR has sufficient cash flows and proper cash management in place, which is an important determinant of the company’s health. CAPR currently has no debt on its balance sheet. It has only utilized funding from its equity capital to run the business, which is typically normal for a small-cap company. Investors’ risk associated with debt is virtually non-existent and the company has plenty of headroom to grow debt in the future, should the need arise.
Next Steps:
For Capricor Therapeutics, there are three fundamental factors you should further research:
Historical Performance: What has CAPR’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
Dividend Income vs Capital Gains: Does CAPR return gains to shareholders through reinvesting in itself and growing earnings, or redistribute a decent portion of earnings as dividends? Our historical dividend yield visualization quickly tells you what your can expect from CAPR as an investment.
Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of CAPR? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.
